Back to Search
Start Over
CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients
- Source :
- Oral Oncology. 106:104720
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Objectives Oral and oropharyngeal squamous cell carcinoma (OOPSCC) is a debilitating disease. Salivary rinses contain soluble tumor markers including CD44 (solCD44) and total protein (TP) that may aid detection and prognosis of these aggressive tumors. Here we aim to examine the relationship between these salivary biomarkers and tissue markers p16 and CD44 and determine whether these markers can predict progression-free survival (PFS) and overall survival (OS). Materials and methods Prospective study to update biomarkers using oral rinses and tissues from OOPSC patients enrolled between 2007 and 2012 at an academic tertiary referral center. 64 cases from a 300-subject case-control study with archived tissue for immunohistochemistry were included. Results 82.8% were male, 84.4% were ever smokers, 70.3% had disease stage T3-T4, and 57.8% presented with nodal disease. Nineteen patients (25%) were p16 positive. The group with strong tissue CD44 expression in membrane and cytoplasm had higher levels of solCD44 (mean 10.73 ng/ml) than other groups (5.47 ng/ml) (p = 0.033). TP levels were significantly reduced in oral rinses from subjects with p16 universal gross tumor tissue staining (mean 0.80 vs. 1.08 mg/ml; p = 0.039). On multivariate analysis, universal CD44 gross tissue staining and TP levels ≥ 1 mg/ml demonstrated poorer PFS, with the latter also affecting OS. Poorer survival was associated with soluble CD44 ≥ 5.33 ng/ml and TP ≥ 1 mg/ml. Conclusions Direct associations were found between high solCD44 levels and strong membrane and cytoplasmic CD44 expression, and between high TP levels and peripheral/mixed p16 gross staining. Poorer PFS and OS are significantly associated with higher levels of solCD44 and protein in oral rinses.
- Subjects :
- Male
Cancer Research
medicine.medical_specialty
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Internal medicine
Biomarkers, Tumor
medicine
Humans
Prospective Studies
Stage (cooking)
Saliva
030223 otorhinolaryngology
Prospective cohort study
biology
business.industry
CD44
Head and neck cancer
Cancer
Middle Aged
Prognosis
medicine.disease
Staining
Oropharyngeal Neoplasms
Hyaluronan Receptors
Oncology
030220 oncology & carcinogenesis
biology.protein
Oral rinses
Immunohistochemistry
Female
Mouth Neoplasms
Oral Surgery
business
Subjects
Details
- ISSN :
- 13688375
- Volume :
- 106
- Database :
- OpenAIRE
- Journal :
- Oral Oncology
- Accession number :
- edsair.doi.dedup.....95f4e58a36d226c937bce9418725ca75
- Full Text :
- https://doi.org/10.1016/j.oraloncology.2020.104720